Drug Development
Clinician- and Patient-reported Endpoints in CNS Orphan Drug Clinical Trials: ISCTM Position Paper on Best Practices for Endpoint Selection, Validation, Training, and Standardization
by Joan Busner, PhD; Gahan Pandina, PhD; Silvia Zaragoza domingo
October 1, 2021
No Comments
